AstraZeneca finds Pfizer bid a bitter pill to swallow
#############################
Video Source: www.youtube.com/watch?v=zp2ZQYnZ2HQ
http://goo.gl/EX3rvQ • The boss of British pharmaceutical giant AstraZeneca, Pascal Soriot, has been emphasising the firm's long term independent prospects, amid talk of a take-over by rival Pfizer. • Pfizer said it had made a move earlier this year but it looks as though AstraZeeneca is playing hard to get. Pfizer's £46.61 per share deal now looks out of date and Astra shares rose around fifteen percent on Monday. • Dr. Mick Cooper from Edison Investment Research looks at the possible one hundred billion dollar deal and asks if these mega mergers actually offer long term value.
#############################